Status:

COMPLETED

Comparative Study of Three IOL Power Calculation Formulae for Asian Eyes Shorter Than 22mm or Longer Than 25mm

Lead Sponsor:

Singapore National Eye Centre

Collaborating Sponsors:

Singapore Eye Research Institute

Conditions:

Cataract

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

Implantation of an intraocular lens is the gold standard in modern day cataract surgery. The appropriate lens power needed to achieve the desired refractive outcome can be calculated with a whole var...

Detailed Description

Our primary objective is to compare three IOL power calculation formulae and determine the most appropriate formula for accurate prediction of postoperative refractive error in Asian eyes with axial l...

Eligibility Criteria

Inclusion

  • Eyes with significant cataract and suitable for phacoemulsification and primary implantation of posterior chamber intraocular lens.
  • Cataract as the only ophthalmic pathology causing significant visual impairment.
  • Axial length less than 22mm or more than 25mm, as measured by Zeiss IOL Master.
  • Evidence of a personally signed and dated informed consent document indicating the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the trial.
  • Patient is willing and able to comply with scheduled visits and other study procedures.

Exclusion

  • Presence of other ophthalmic pathology causing visual impairment: amblyopia, glaucoma, optic neuropathy, age related macular degeneration, macular oedema, retinal detachment, proliferative diabetic retinopathy, ocular inflammation.
  • Previous intraocular or corneal surgery (including refractive surgery).
  • Corneal opacities or irregularities: previous scarring, dystrophy, ectasia
  • Corneal astigmatism greater than 1.5 dioptres.
  • Axial length unable to be measured by the Zeiss IOL master.
  • Other ocular surgery at time of cataract extraction.
  • Uncontrolled diabetes.
  • Any neurological condition which may interfere with performance of required tests.
  • Other severe acute or chronic medical or psychiatric condition that may increase the risk associated with study participation or may interfere with the interpretation of study results.
  • Surgical exclusion criteria
  • The patient will not be included in the study if any of the following complications are encountered during surgery:
  • Inability to achieve secure 'in-the-bag' placement of the IOL (i.e. due to posterior capsule rupture, radial tear in capsulorhexis, vitreous loss, zonular rupture)
  • Use of corneal sutures.
  • Multiple operative procedures at the time of IOL implantation.
  • Post-implantation exclusion criteria:
  • Haptic not in the capsular bag.
  • Decentration of the IOL of more than 1.0mm.
  • Other ocular pathology causing visual impairment that were not apparent prior to surgery (e.g. age related macular degeneration, macular oedema, glaucoma, retinal detachment).

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2009

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT00347516

Start Date

December 1 2005

End Date

December 1 2009

Last Update

May 12 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore National Eye Centre

Singapore, Singapore, 168751

Comparative Study of Three IOL Power Calculation Formulae for Asian Eyes Shorter Than 22mm or Longer Than 25mm | DecenTrialz